Tag: Dhananjay Singh
BioVoice eMagazine November 2025 | Issue 10 | Volume 6
The Cover Story tracks how between 2015 and 2025, India’s healthcare and biotech firms transformed CSR from basic compliance to strategic, impact-driven initiatives. Also featuring interviews with: Merck Life Science’s Dhananjay Singh on strengthening India’s R&D and lab infrastructure. Maverick Simulation Solutions’ Anuj Chahal on investing Rs 50 crore in R&D, AI, and immersive learning.
Dhananjay Singh appointed as new Managing Director of Merck Life Science...
Effective April 1, 2024, Dhananjay Singh has taken over from Sreenath NS, who is retiring after 36 years of illustrious service with Merck in India